The interplay between cell signalling and the mevalonate pathway in cancer

Area of Science:

• Biochemistry
• Oncology
• Metabolic pathways

Background:

• The mevalonate (MVA) pathway is crucial for producing sterols and isoprenoids essential for tumor development.
• Oncogenic signaling pathways frequently enhance MVA pathway enzyme activity and expression.
• This highlights a metabolic vulnerability in cancer.

Purpose of the Study:

• To review recent advancements in understanding the MVA pathway's role in cancer.
• To identify therapeutic opportunities for targeting this pathway in cancer patients.
• To explore the potential of repurposing existing drugs, such as statins.

Main Methods:

• Literature review of recent research on the MVA pathway in oncology.
• Analysis of oncogenic signaling pathways affecting MVA metabolism.
• Evaluation of approved drugs for targeting the MVA pathway in cancer.

Main Results:

• The MVA pathway is increasingly recognized as a key driver of tumor growth.
• Several oncogenic pathways modulate MVA pathway enzymes.
• Approved drugs, notably statins, show potential for repurposing against cancer.

Conclusions:

• Targeting the MVA pathway represents a viable therapeutic strategy for cancer.
• Repurposing existing drugs like statins offers a rapid approach to clinical application.
• Exploiting this metabolic vulnerability could significantly improve cancer patient outcomes.